Rankings
▼
Calendar
ZLAB
Zai Lab Limited
$2B
Q2 2021 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$37M
+235.9% YoY
Gross Profit
-$116M
-314.5% margin
Operating Income
-$171M
-461.8% margin
Net Income
-$163M
-442.2% margin
EPS (Diluted)
$-17.60
QoQ Revenue Growth
+83.7%
Cash Flow
Operating Cash Flow
-$66M
Free Cash Flow
-$70M
Stock-Based Comp.
$10M
Balance Sheet
Total Assets
$1.9B
Total Liabilities
$224M
Stockholders' Equity
$1.7B
Cash & Equivalents
$1.8B
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$37M
$11M
+235.9%
Gross Profit
-$116M
$8M
-1534.2%
Operating Income
-$171M
-$84M
-103.1%
Net Income
-$163M
-$81M
-102.6%
Revenue Segments
Zejula
$23M
71%
Optune
$10M
29%
Qinlock
$4,034
0%
← FY 2021
All Quarters
Q3 2021 →
ZLAB Q2 2021 Earnings — Zai Lab Limited Revenue & Financial Results | Market Cap Arena